GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,963,000 | +20.1% | 136,978 | +20.1% | 0.03% | +39.1% |
| Q1 2022 | $4,967,000 | -0.8% | 114,023 | +0.4% | 0.02% | +4.5% |
| Q4 2021 | $5,009,000 | +19.4% | 113,582 | +3.4% | 0.02% | +4.8% |
| Q3 2021 | $4,195,000 | -2.8% | 109,798 | +1.3% | 0.02% | 0.0% |
| Q2 2021 | $4,314,000 | +20.7% | 108,345 | +8.2% | 0.02% | +10.5% |
| Q1 2021 | $3,575,000 | -2.0% | 100,173 | +1.0% | 0.02% | -9.5% |
| Q4 2020 | $3,649,000 | -7.8% | 99,150 | -5.7% | 0.02% | -22.2% |
| Q3 2020 | $3,956,000 | -14.0% | 105,088 | -6.8% | 0.03% | -22.9% |
| Q2 2020 | $4,598,000 | +22.9% | 112,733 | +14.1% | 0.04% | -2.8% |
| Q1 2020 | $3,742,000 | -24.1% | 98,770 | -5.9% | 0.04% | -5.3% |
| Q4 2019 | $4,932,000 | +13.8% | 104,949 | +3.3% | 0.04% | 0.0% |
| Q3 2019 | $4,335,000 | +4.1% | 101,578 | -2.4% | 0.04% | 0.0% |
| Q2 2019 | $4,166,000 | -14.7% | 104,107 | -10.9% | 0.04% | -19.1% |
| Q1 2019 | $4,882,000 | +14.7% | 116,824 | +4.9% | 0.05% | 0.0% |
| Q4 2018 | $4,255,000 | -6.9% | 111,361 | -2.2% | 0.05% | +6.8% |
| Q3 2018 | $4,572,000 | -3.0% | 113,826 | -2.6% | 0.04% | -12.0% |
| Q2 2018 | $4,713,000 | +1.1% | 116,924 | -2.1% | 0.05% | -5.7% |
| Q1 2018 | $4,664,000 | +21.9% | 119,385 | +10.7% | 0.05% | +17.8% |
| Q4 2017 | $3,826,000 | -7.9% | 107,873 | +5.5% | 0.04% | -19.6% |
| Q3 2017 | $4,153,000 | -13.9% | 102,291 | -8.5% | 0.06% | -21.1% |
| Q2 2017 | $4,821,000 | +2.7% | 111,805 | +0.4% | 0.07% | -11.2% |
| Q1 2017 | $4,693,000 | +14.7% | 111,308 | +4.7% | 0.08% | +3.9% |
| Q4 2016 | $4,093,000 | -20.8% | 106,283 | -11.3% | 0.08% | -19.8% |
| Q3 2016 | $5,169,000 | +10.3% | 119,854 | +10.8% | 0.10% | -3.0% |
| Q2 2016 | $4,688,000 | +18.7% | 108,162 | +11.1% | 0.10% | +11.2% |
| Q1 2016 | $3,948,000 | -2.6% | 97,353 | -3.0% | 0.09% | -7.3% |
| Q4 2015 | $4,052,000 | +20.0% | 100,411 | +14.3% | 0.10% | -1.0% |
| Q3 2015 | $3,377,000 | -7.8% | 87,829 | -0.1% | 0.10% | -4.0% |
| Q2 2015 | $3,661,000 | -1.2% | 87,901 | +9.5% | 0.10% | -3.8% |
| Q1 2015 | $3,704,000 | +39.1% | 80,262 | +28.9% | 0.10% | +28.0% |
| Q4 2014 | $2,662,000 | +11.4% | 62,286 | +19.8% | 0.08% | +17.1% |
| Q3 2014 | $2,390,000 | +1.1% | 51,983 | +17.5% | 0.07% | -15.7% |
| Q2 2014 | $2,365,000 | +13.6% | 44,228 | +13.5% | 0.08% | +5.1% |
| Q1 2014 | $2,081,000 | +21.6% | 38,957 | +21.5% | 0.08% | +12.9% |
| Q4 2013 | $1,712,000 | +6.5% | 32,057 | -0.0% | 0.07% | 0.0% |
| Q3 2013 | $1,608,000 | +8.6% | 32,061 | +8.3% | 0.07% | -6.7% |
| Q2 2013 | $1,480,000 | – | 29,609 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |